Futura Medical (LON:FUM) Trading 8% Higher – What’s Next?

Futura Medical plc (LON:FUM)’s stock price traded up 8% during mid-day trading on Tuesday . The company traded as high as GBX 0.78 and last traded at GBX 0.70. 926,498 shares changed hands during trading, a decline of 85% from the average session volume of 6,167,144 shares. The stock had previously closed at GBX 0.65.

Futura Medical Trading Up 8.0%

The stock’s 50-day simple moving average is GBX 0.98 and its 200-day simple moving average is GBX 1.15. The stock has a market cap of £4.08 million, a price-to-earnings ratio of -0.25 and a beta of 0.01.

Futura Medical (LON:FUM) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The business had revenue of GBX 170 million for the quarter. On average, equities research analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.